Moderna (MRNA) reported Q3 FY 2021 earnings of $7.70 per share (versus -$0.59 per share in Q3 FY 2020), missing analysts’ consensus estimate of $9.42 per share.
The company’s quarterly revenues amounted to $4.969 bln (+3065.0% y/y), missing analysts’ consensus estimate of $6.285 bln.
MRNA fell to $307.76 (-11.03%) in pre-market trading.
